SEEGENE INC.

Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning concepts into products through its pioneering R&D activities. Founded in Seoul in 2000 and with subsidiaries in Rockville, Maryland, USA and Eschborn, Germany, Seegene has developed innovative technology platforms including ACP™ (Annealing Control Primer), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection). With these cutting-edge molecular diagnostic (MoDx) technologies applied to diagnostic kits and other tools, Seegene has enhanced the sensitivity and specificity of PCR (polymerase chain reaction) to unprecedented levels. Seegene provides multiplex PCR products which target and detect genes of multiple pathogens simultaneously, saving testing time and cost. Seegene will continue to set new standards in MoDx and provide new, cost effective innovations.